{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:41:35Z","timestamp":1788871295747,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012527","name":"Office of the Higher Education Commission","doi-asserted-by":"crossref","award":["RMU5380012"],"award-info":[{"award-number":["RMU5380012"]}],"id":[{"id":"10.13039\/100012527","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000690","name":"Nation Research Council of Thailand","doi-asserted-by":"publisher","award":["NG P 0812555"],"award-info":[{"award-number":["NG P 0812555"]}],"id":[{"id":"10.13039\/501100000690","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Research Universities"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.jpba.2014.08.032","type":"journal-article","created":{"date-parts":[[2014,9,6]],"date-time":"2014-09-06T12:33:17Z","timestamp":1410006797000},"page":"119-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Stability indicating MEKC method for the determination of gliclazide and its specified impurities"],"prefix":"10.1016","volume":"102","author":[{"given":"Athiporn","family":"Doomkaew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brompoj","family":"Prutthiwanasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena","family":"Suntornsuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2014.08.032_bib0005","series-title":"International Conference on Harmonization, International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)","article-title":"Stability testing of new drug substance and product","author":"ICH","year":"2003"},{"key":"10.1016\/j.jpba.2014.08.032_bib0010","series-title":"Basic & Clinical Pharmacology","first-page":"743","article-title":"Pancreatic hormones and antidiabetic drugs","author":"Kennedy","year":"2012"},{"key":"10.1016\/j.jpba.2014.08.032_bib0015","series-title":"Harrison's Principles of Internal Medicine","first-page":"2152","article-title":"Diabetes mellitus","author":"Powers","year":"2005"},{"key":"10.1016\/j.jpba.2014.08.032_bib0020","series-title":"Goodman & Gilman's The Pharmacological Basic of Therapeutics","first-page":"743","article-title":"Endocrine pancreas and pharmacotherapy of diabetes mellitus and hypoglycemia","author":"Powers","year":"2011"},{"key":"10.1016\/j.jpba.2014.08.032_bib0025","series-title":"Contemporary Endocrinology Type 2 Diabetes Mellitus","first-page":"2","article-title":"Epidemiology of type 2 diabetes","author":"Shaw","year":"2008"},{"key":"10.1016\/j.jpba.2014.08.032_bib0030","series-title":"Martindale","first-page":"396","article-title":"Antidiabetics: biguanide, sulfonylurea","author":"Sweetman","year":"2007"},{"key":"10.1016\/j.jpba.2014.08.032_bib0035","series-title":"British Pharmacopoeia","year":"2011"},{"key":"10.1016\/j.jpba.2014.08.032_bib0040","series-title":"Safety Data Sheet: Gliclazide Impurity B","author":"European Directorate for the Quality of Medicines & Healthcare","year":"2007"},{"key":"10.1016\/j.jpba.2014.08.032_bib0045","series-title":"Safety Data Sheet: Gliclazide Impurity F [Internet]","author":"European Directorate for the Quality of Medicines & HealthCare","year":"2007"},{"key":"10.1016\/j.jpba.2014.08.032_bib0050","doi-asserted-by":"crossref","first-page":"144","DOI":"10.59566\/IJBS.2012.8144","article-title":"Simultaneous determination of metformin, nateglinide and gliclazide in pharmaceutical preparations using micellar liquid chromatography","volume":"8","author":"El-Wasseef","year":"2012","journal-title":"Int. J. Biomed. Sci."},{"key":"10.1016\/j.jpba.2014.08.032_bib0055","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jchromb.2007.03.022","article-title":"Development of a RP-HPLC method for screening potentially counterfeit anti-diabetic drugs","volume":"853","author":"Yao","year":"2007","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2014.08.032_bib0060","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0731-7085(00)00493-3","article-title":"Ion-pair liquid chromatography technique for the estimation of metformin in its multicomponent dosage forms","volume":"25","author":"Vasudevan","year":"2001","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2014.08.032_bib0065","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.5897\/AJPP10.106","article-title":"Determination of gliclazide in a tablet dosage form in the presence of metformin hydrochloride by ion pair-reversed phase liquid chromatographic technique","volume":"11","author":"Rao","year":"2011","journal-title":"Afr. J. Pharm. Pharmacol."},{"key":"10.1016\/j.jpba.2014.08.032_bib0070","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jpba.2006.05.003","article-title":"Application of monolithic column in quantification of gliclazide in human plasma by liquid chromatography","volume":"42","author":"Foroutan","year":"2006","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2014.08.032_bib0075","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.chroma.2004.12.097","article-title":"High-performance liquid chromatography with electrochemical detection for analysis of gliclazide in plasma","volume":"1088","author":"Kuo","year":"2005","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2014.08.032_bib0080","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jpba.2004.02.025","article-title":"Quantification of gliclazide by semi-micro high-performance liquid chromatography: application to a bioequivalence study of two formulations in healthy subjects","volume":"35","author":"Park","year":"2004","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2014.08.032_bib0085","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jchromb.2004.12.018","article-title":"The development and validation of liquid chromatography method for the simultaneous determination of metformin and glipizide, gliclazide, glibenclamide or glimiperide in plasma","volume":"817","author":"Aburuz","year":"2005","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2014.08.032_bib0090","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1570-0232(02)00951-0","article-title":"A simple and sensitive HPLC method for determination of gliclazide in human serum","volume":"785","author":"Rouini","year":"2003","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2014.08.032_bib0095","first-page":"728","article-title":"Validation of a HPLC for the simultaneous analysis of metformin and gliclazide in human plasma","volume":"57","author":"Ranetti","year":"2009","journal-title":"Farmacia"},{"key":"10.1016\/j.jpba.2014.08.032_bib0100","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/jms.907","article-title":"Simultaneous determination of metformin and gliclazide in human plasma by liquid chromatography\u2013tandem mass spectrometry: application to a bioequivalence study of two formulations in healthy volunteers","volume":"40","author":"Zhong","year":"2005","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.jpba.2014.08.032_bib0105","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jpba.2005.05.017","article-title":"Determination of aminoheterocycle and azabicycle in gliclazide bulk by capillary zone electrophoresis with amperometric detection","volume":"39","author":"Lv","year":"2005","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2014.08.032_bib0110","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/jaoac\/84.6.1695","article-title":"Determination of gliclazide in pharmaceutical preparations by capillary gas chromatography with cool on-column injection and elimination of the matrix effect","volume":"84","author":"Krzek","year":"2001","journal-title":"J. AOAC Int."},{"key":"10.1016\/j.jpba.2014.08.032_bib0115","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4103\/0250-474X.62231","article-title":"A supercritical fluid chromatography\/tandem mass spectrometry method for the simultaneous quantification of metformin and gliclazide in human plasma","volume":"72","author":"Agrawal","year":"2010","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2014.08.032_bib0120","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.farmac.2003.08.007","article-title":"Spectrophotometric determination of gliclazide in pharmaceuticals and biological fluids through ternary complex formation with eosin and palladium(II)","volume":"59","author":"El-Enany","year":"2004","journal-title":"Farmaco"},{"key":"10.1016\/j.jpba.2014.08.032_bib0125","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/jaoac\/86.2.209","article-title":"Spectrofluorimetric and spectrophotometric determination of gliclazide in pharmaceuticals by derivatization with 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole","volume":"86","author":"El-Enany","year":"2003","journal-title":"J. AOAC. Int."},{"key":"10.1016\/j.jpba.2014.08.032_bib0130","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1365\/s10337-007-0394-4","article-title":"Forced degradation study on gliclazide and application of validation stability-indicating HPLC\u2013UV in stability testing of gliclazide tablets","volume":"66","author":"Bansal","year":"2007","journal-title":"Chromatographia"},{"key":"10.1016\/j.jpba.2014.08.032_bib0135","first-page":"80","article-title":"Stress degradation study of two oral antidiabetics, gliclazide and glipizide and chemical analysis by LC and LC\/MS methods","volume":"12","author":"Gumieniczek","year":"2014","journal-title":"Cent. Eur. J. Chem."},{"key":"10.1016\/j.jpba.2014.08.032_bib0140","first-page":"1","article-title":"Guidance on conduct of stress tests to determine inherent stability of drugs","volume":"24","author":"Singh","year":"2000","journal-title":"Pharm. Technol. On-line"},{"key":"10.1016\/j.jpba.2014.08.032_bib0145","series-title":"International Conference on Harmonization Topic Q2(R1), Validation of Analytical Procedures","year":"2007"},{"key":"10.1016\/j.jpba.2014.08.032_bib0150","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.chemosphere.2011.06.041","article-title":"Uptake and translocation of metformin, ciprofloxacin and narasin in forage and crop plants","volume":"85","author":"Eggen","year":"2011","journal-title":"Chemosphere"},{"key":"10.1016\/j.jpba.2014.08.032_bib0155","first-page":"13","article-title":"Bioequivalence of two kinds of gliclazide capsules in human","volume":"41","author":"Fu","year":"2001","journal-title":"Acta Academiae Medicinae Jiangxi"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708514004166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708514004166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T08:50:35Z","timestamp":1759999835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708514004166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":31,"alternative-id":["S0731708514004166"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2014.08.032","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stability indicating MEKC method for the determination of gliclazide and its specified impurities","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2014.08.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}